Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Asthma

  Free Subscription


30.04.2018

2 Allergy
1 Ann Allergy Asthma Immunol
1 BMC Pediatr
1 Clin Exp Allergy
1 J Allergy Clin Immunol
4 J Asthma
1 Lancet Respir Med
1 Respir Med
1 Respir Res


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Allergy

  1. CHAUVEAU A, Dalphin ML, Mauny F, Kaulek V, et al
    Skin prick tests and specific IgE in 10 year old children: agreement and association with allergic diseases.
    Allergy. 2017 Feb 24. doi: 10.1111/all.13148.
    PubMed     Text format     Abstract available

  2. VALERO A, Quirce S, Davila I, Delgado J, et al
    Allergic respiratory disease: different allergens, different symptoms.
    Allergy. 2017 Feb 16. doi: 10.1111/all.13141.
    PubMed     Text format     Abstract available


    Ann Allergy Asthma Immunol

  3. STRAUSS RA, Jawhari N
    Mepolizumab in the treatment of severe eosinophilic asthma: "results from a physician in the field".
    Ann Allergy Asthma Immunol. 2018 Apr 20. pii: S1081-1206(18)30302.
    PubMed     Text format    


    BMC Pediatr

  4. AZIZPOUR Y, Delpisheh A, Montazeri Z, Sayehmiri K, et al
    Effect of childhood BMI on asthma: a systematic review and meta-analysis of case-control studies.
    BMC Pediatr. 2018;18:143.
    PubMed     Text format     Abstract available


    Clin Exp Allergy

  5. KOLLMEIER AP, Greenspan A, Xu XL, Silkoff PE, et al
    Phase 2a, randomized, double-blind, placebo-controlled, multicenter, parallel-group study of an H4 R-antagonist (JNJ-39758979) in adults with uncontrolled asthma.
    Clin Exp Allergy. 2018 Apr 23. doi: 10.1111/cea.13154.
    PubMed     Text format     Abstract available


    J Allergy Clin Immunol

  6. ZHU J, Message SD, Mallia P, Kebadze T, et al
    Bronchial mucosal Interferon-alpha/beta and pattern recognition receptor expression in experimental rhinovirus-induced asthma exacerbations.
    J Allergy Clin Immunol. 2018 Apr 23. pii: S0091-6749(18)30610.
    PubMed     Text format     Abstract available


    J Asthma

  7. TAY TR, Wong HS, Tee A
    Predictors of future exacerbations in a multi-ethnic Asian population with asthma.
    J Asthma. 2018 Apr 24:1-8. doi: 10.1080/02770903.2018.1458862.
    PubMed     Text format     Abstract available

  8. RADHAKRISHNAN D, Shariff SZ, To T
    The influence of prenatal mental health service use on the incidence of childhood asthma: a population-based cohort study.
    J Asthma. 2018 Apr 25:1-35. doi: 10.1080/02770903.2018.1466313.
    PubMed     Text format     Abstract available

  9. SOTO-MARTINEZ ME, Yock-Corrales A, Camacho-Badilla K, Abdallah S, et al
    The current prevalence of asthma, allergic rhinitis, and eczema related symptoms in school-aged children in Costa Rica.
    J Asthma. 2018 Apr 25:1-9. doi: 10.1080/02770903.2018.1455860.
    PubMed     Text format     Abstract available

  10. KIRKLAND SW, Vandermeer B, Campbell S, Villa-Roel C, et al
    Evaluating the effectiveness of systemic corticosteroids to mitigate relapse in children assessed and treated for acute asthma: A network meta-analysis.
    J Asthma. 2018 Apr 25:0. doi: 10.1080/02770903.2018.1467444.
    PubMed     Text format     Abstract available


    Lancet Respir Med

  11. BUSSE P, Wechsler ME
    Identification of remission in adult-onset asthma.
    Lancet Respir Med. 2018 Apr 23. pii: S2213-2600(18)30175.
    PubMed     Text format    


    Respir Med

  12. KWON JW, Chang HS, Heo JS, Bae DJ, et al
    Characteristics of asthmatics with detectable IL-32gamma in induced sputum.
    Respir Med. 2017;129:85-90.
    PubMed     Text format     Abstract available


    Respir Res

  13. BLOECHLIGER M, Reinau D, Spoendlin J, Chang SC, et al
    Adverse events profile of oral corticosteroids among asthma patients in the UK: cohort study with a nested case-control analysis.
    Respir Res. 2018;19:75.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Asthma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: